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Reducing Readmissions for Newborns with Hyperbilirubinemia 
Kristi Patterson, RN BSN 
Performance Improvement, Value and Analytics 
St. Cloud Hospital, St. Cloud, Minnesota 
pattersonk@centracare.com 
Purpose Statement 
The purpose of this project is to reduce 30 day 
readmission rates by 20% for normal newborns with 
hyperbilirubinemia on their index admission by 
utilizing the AAP clinical practice guideline including: 
 
•Utilizing the AAP nomogram based on age in 
hours  
 
•Screening prior to discharge  
 
•Implementing the recommended interventions 
at discharge 
 
•  Synthesis of Evidence 
Over 40 articles were reviewed and graded utilizing the AACN 

















 Team Members 
•Carla Bieniek, Case Manager 
•Melissa Erickson, Clinical Resource Nurse 
•Amy Junes, Educator 
•Dr. Kathy Kulus, Pediatric Hospitalist Program 
•Terri Nicoski, Nursery Nurse 
•Jeannie Olson, Core Charge 
•Kristi Patterson, Performance Improvement 
 
Ad hoc Members: 
•Michelle Scepaniak, Case Manager 
•Dr. Elaina Lee, Pediatrician 
Pre/Post Measures 
Table 1. 


























Outcome Measure:  30 Day Readmission by Fiscal Year 





87% 77% 76% 
96% 100% 88% 
TcB within 24 hrs Risk factors for 
hyperbili documented 
DC exam addresses 
jaundice status 
Follow up within 2 
days if DC <72 hrs 
Baseline Remeasurement 
• Align policy, order set, & documentation with 
Amercian Academy of Pediatrics Clinical 
Practice Guideline 
• Implement amber tubes for lab draws to 
minimize light exposure 
• Automate age in hours calculation 
Policy & 
Practice 
• Revise provider discharge summary template 
• Create nursing flowsheet group to standardize 
assessment & documentation 





• Embed BiliTool into Epic 
• Initiate TcB on all infants within 24 hrs & repeat 
at least every 24 hrs until DC 
• Phototherapy initiated by nursing as indicated 
by the BiliTool 
Early Screening 
& Intervention 
• Follow up based on DC time & risk assessment 
• Establish DME availability 365 days/yr & 
consistent mode of  delivery 
• Seek funds for home phototherapy equipment 
• Home Care & OP Clinic collaborative 
Care  
Transitions 
• Standardize content 




Alkaly, A.L., Brese, C.J., & Simmons, C.F. (2010). Decreased neonatal jaundice 
readmission rate after implementing hyperbilirubinemia guidelines and universal 
screening for bilirubin.  Clinical Pediatrics,49(9), 830-833. 
Allegro, D. & Young, M. (2009).  Program helps in early identification and treatment of 
neonatal hyperbilirubinemia.  Canadian Nurse, 105(6), 6-7. 
American Academy of Pediatrics.  (2004).  Management of hyperbilirubinemia in the 
newborn infant 35 or more weeks of gestation.  Pediatrics, 114 (1), 297-316.  
Barrington, K. J. & Sankaran, K. (2007). Guidelines for detection, management and 
prevention of hyperbilirubinemia in term and later preterm newborn infants (35 or more 
weeks’ gestation).  Pediatric Child Health, 12(5), 401-407. 
Bhutani, V. K., Johnson, L., & Sivieri, E. M.  (1999).  Predictive ability of a predischarge 
hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy 
term and near-term newborns.  Pediatrics, 103(1),  6-14. 
National Institute for Health and Clinical Excellence.  (2010).  Neonatal jaundice quick 










FY2012 FY2013 FY2014 FY2015* 
30 Day Readmissions for Newborns with Hyperbilirubinemia 
Readmitted with Jaundice 
*FY2015 through  February 
Goal:  < 2.7% 
• Universal pre-discharge TSB 
• TcB not to be used in isolation of 
clinical presentation or based on 
a single reading 
Evidence Level B:    
Well-designed controlled 
studies, both randomized and 
nonrandomized, with results 
that consistently support a 
specific action, intervention, or 
treatment  
• Systematic assessment of all newborns 
prior to discharge 
• Report age in hrs 
• Provide phototherapy equip before DC  
• TSB/TcB between 24-72 h in all infants 
Evidence Level D: 
Peer-reviewed professional 
organizational standards, with 
clinical studies to support 
recommendations     
• Screening is a key intervention 
• Visual inspection alone is 
insufficient 
Evidence Level E: 
Theory-based evidence from 
expert opinion or multiple 
case reports  
Table 1. 
AACN Level of Evidence & Key Findings 
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age in hours  
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Outcome Measure:  30 Day Readmission by Fiscal Year 







96% 100% 88% 
TcB within 24 hrs Risk factors for 
hyperbili documented 
DC exam addresses 
jaundice status 
Follow up within 2 
days if DC <72 hrs 
Baseline Remeasurement 
• Align policy, order set, & documentation with 
AAP CPG 
• Implement amber tubes for lab draws 
Policy & 
Practice 
• Coder & Provider education 
• Revise provider DC summary template 
• Create nursing docflowsheet group 
Epic, Coding, 
Documentation 
• Embed BiliTool into Epic 
• TcB on all infants within 24 hours & repeat at 
least every 24 hrs until DC 
• Nursing initiates phototherapy per BiliTool 
Early Screening 
& Intervention 
• Standardize content 
• Educate all newborn families at discharge 
Patient 
Education 
• Follow up based on time of discharge & risk 
assessment 
• DME:  establish availability 365 days/year 




Alkaly, A.L., Brese, C.J., & Simmons, C.F. (2010). Decreased neonatal 
jaundice readmission rate after implementing hyperbilirubinemia 
guidelines and universal screening for bilirubin.  Clinical Pediatrics,49(9), 
830-833. 
Allegro, D. & Young, M. (2009).  Program helps in early identification and 
treatment of neonatal hyperbilirubinemia.  Canadian Nurse, 105(6), 6-7. 
American Academy of Pediatrics.  (2004).  Management of 
hyperbilirubinemia in the newborn infant 35 or more weeks of gestation.  
Pediatrics, 114 (1), 297-316.  
Barrington, K. J. & Sankaran, K. (2007). Guidelines for detection, 
management and prevention of hyperbilirubinemia in term and later 
preterm newborn infants (35 or more weeks’ gestation).  Pediatric Child 
Health, 12(5), 401-407. 
Bhutani, V. K., Johnson, L., & Sivieri, E. M.  (1999).  Predictive ability of a 
predischarge hour-specific serum bilirubin for subsequent significant 
hyperbilirubinemia in healthy term and near-term newborns.  Pediatrics, 
103(1),  6-14. 
National Institute for Health and Clinical Excellence.  (2010).  Neonatal 




Level Description   
#  Key 
Articles Key Findings 
B Well-designed controlled studies, both 
randomized and nonrandomized, with 
results that consistently support a specific 
action, intervention, or treatment  
2 •Universal pre-discharge TSB 
•TcB not to be used in isolation of clinical 
presentation or based on a single reading 
D Peer-reviewed professional organizational 
standards, with clinical studies to support 
recommendations  
3 •Systematic assessment of all newborns 
prior to discharge 
•Report age in hrs 
•Provide phototherapy equip before 
discharge  
•TSB/TcB between 24-72 h in all infants 
E Theory-based evidence from expert 
opinion or multiple case reports  
1 •Screening is a key intervention 
•Visual inspection alone is insufficient 
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Pre/Post Measures 
Table 1. 
Process Measures:  Pre- and Post-Implementation  
EBP Practice Change 
1. Engage nurses and physicians 
2. Align policy & practice with the AAP Clinical 
Practice Guideline 
3. Early screening & intervention 
4. Standardize  assessments,  interventions, 
and documentation 
5. Address care transitions 
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96% 100% 88% 
TcB within 24 hrs Risk factors for 
hyperbili documented 
DC exam addresses 
jaundice status 
Follow up within 2 
days if DC <72 hrs 
Baseline July-September 2014 
Your name & credentials 
EBP Project Poster Title 
Your email here 
Purpose Statement 
The purpose of this project is to reduce 
30 day readmission rates by 20% for 
normal newborns with hyperbilirubinemia 
on their index admission by utilizing the 
AAP clinical practice guideline including: 
 
• Utilizing the AAP nomogram 
based on age in hours  
•Screening prior to discharge  
•Implementing the 
recommended interventions at 
discharge 
 
Synthesis of Evidence 
Include bullet points of your  literature 
findings, include the grading as 
appropriate 




Use this template if you want to emphasizes 
measurements/outcomes 
 
Include charts, graphs, policies, orders, Epic screen shots 
– what ever you can do to show your results 
Your pre and post data should be here 
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EBP Project Poster Title 
Your email here 
Purpose Statement 
Font size recommended at 10 
Synthesis of Evidence 
Include bullet points of your  literature 
findings, include the grading as 
appropriate 




Use this template if you want to emphasizes 
measurements/outcomes 
 
Include charts, graphs, policies, orders, Epic screen shots 
– what ever you can do to show your results 
Your pre and post data should be here 
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Your name & credentials 
Research Study Poster Title 
Your email here 
Introduction 




Include bullet points of your  literature 
findings, include the grading as 
appropriate 
• Bullet  
 
Analysis/Results 
Include charts, graphs, policies, orders, Epic screen shots 
– what ever you can do to show your results 
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Institution, St. Cloud, Minnesota 
Your name & credentials 
Performance Improvement Poster Title 
Your email here 
Plan 
Identify and analyze the problem 
Do 
Identify the solution 




Gather data and evaluate  
 
Include charts, graphs, policies, orders, Epic screen shots 
– what ever you can do to show your results 
Your pre and post data should be here 
 
Act 
Standardize the solution – systematic 
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